James Good, DPM
Podiatrist · Gladstone, MONPI 1639135825
Payments from drug & device makers
What this record shows
This record is dominated by other: $4,050 of the $5,562 with a category attached, or 72.8%. Acera Surgical, Inc. accounts for 74.4% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2022 at $4,218 and has fallen 96.7% since, to $138 in 2025.
Across 36 payments — averaging $154.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Acera Surgical, Inc.$4K
- Paragon 28, Inc.$530
- Organogenesis Inc.$341
- Stryker$149
- Johnson & Johnson$132
- Surgenex LLC$122
- plus $152 from 7 others
What the payments were for
- Travel & lodging$4819%
- Food & beverage$1,03119%
- Other$4,05073%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Acera Surgical, Inc. | 6 | $4,136 |
| Paragon 28, Inc. | 3 | $530 |
| Organogenesis Inc. | 9 | $341 |
| Stryker(2 entities) | 4 | $149 |
| Johnson & Johnson | 2 | $132 |
| Surgenex LLC | 2 | $122 |
| KCI USA, Inc. | 2 | $34 |
| Integra Lifesciences Corporation | 2 | $32 |
| Smith+Nephew | 2 | $26 |
| Derma Sciences, Inc. | 1 | $19 |
| Acumed LLC | 1 | $16 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $14 |
| Merck | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Restrata Wound Matrix$4,050
- TTC NAIL$325
- ACTIVCORE NAIL$156
- PuraPly$119
- XARELTO$101
How this compares
$5,562 in reported general payments places this provider in the 80th percentile of 105 podiatrist providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 68 | $1,165 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 16 | $388 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 30 | $284 |
| Oxycodone Hcl | 40 | $231 |
| Cephalexin | 27 | $191 |
| Methylprednisolone | 31 | $174 |
| Mupirocin | 20 | $130 |
| Meloxicam | 27 | $77 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Gladstone
- Kori TaylorGladstone$1K
- William DukeJefferson City$54K
- Kiera Benge-SheaSaint Louis$28K
- Thomas BoldryLiberty$19K
- Ryan FrankIndependence$15K
- Neil ErmitanoSaint Louis$14K
- John HarnessOverland$14K
- Brittany StaplesCreve Coeur$13K
- Daniel NarowitzSaint Louis$12K
- Jay MoradiaSaint Louis$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.